Ramos-Álvarez Irene, Moreno Paola, Mantey Samuel A, Nakamura Taichi, Nuche-Berenguer Bernardo, Moody Terry W, Coy David H, Jensen Robert T
Digestive Diseases Branch, NIDDK, National Institutes of Health, Bethesda, MD 20892-1804, United States.
Center for Cancer Research, Office of the Director, NCI, National Institutes of Health, Bethesda, MD 20892-1804, United States.
Peptides. 2015 Oct;72:128-44. doi: 10.1016/j.peptides.2015.04.026. Epub 2015 May 11.
This following article is written for Prof. Abba Kastin's Festschrift, to add to the tribute to his important role in the advancement of the role of peptides in physiological, as well as pathophysiological processes. There have been many advances during the 35 years of his prominent role in the Peptide field, not only as editor of the journal Peptides, but also as a scientific investigator and editor of two volumes of the Handbook of Biological Active Peptides [146,147]. Similar to the advances with many different peptides, during this 35 year period, there have been much progress made in the understanding of the pharmacology, cell biology and the role of (bombesin) Bn receptors and their ligands in various disease states, since the original isolation of bombesin from skin of the European frog Bombina bombina in 1970 [76]. This paper will briefly review some of these advances over the time period of Prof. Kastin 35 years in the peptide field concentrating on the advances since 2007 when many of the results from earlier studies were summarized [128,129]. It is appropriate to do this because there have been 280 articles published in Peptides during this time on bombesin-related peptides and it accounts for almost 5% of all publications. Furthermore, 22 Bn publications we have been involved in have been published in either Peptides [14,39,55,58,81,92,93,119,152,216,225,226,231,280,302,309,355,361,362] or in Prof. Kastin's Handbook of Biological Active Peptides [137,138,331].
以下这篇文章是为阿巴·卡斯汀教授的纪念文集而写,以进一步颂扬他在肽类物质于生理及病理生理过程中作用的推进方面所发挥的重要作用。在他于肽类领域发挥突出作用的35年里取得了诸多进展,他不仅担任《肽》杂志的编辑,还是一名科学研究者以及两卷本《生物活性肽手册》[146,147]的编辑。与许多不同肽类物质的进展相似,在这35年期间,自1970年从欧洲青蛙铃蟾(Bombina bombina)皮肤中首次分离出蛙皮素(bombesin)以来,在对蛙皮素(Bn)受体及其配体在各种疾病状态下的药理学、细胞生物学及作用的理解方面也取得了很大进展。本文将简要回顾卡斯汀教授在肽类领域35年期间的部分进展,重点关注自2007年起的进展,当时早期许多研究结果已得到总结[128,129]。这样做是恰当的,因为在此期间《肽》杂志上发表了280篇关于蛙皮素相关肽类的文章,几乎占所有出版物的5%。此外,我们参与的22篇关于蛙皮素的出版物发表在《肽》杂志[14,39,55,58,81,92,93,119,152,216,225,226,231,280,302,309,355,361,362]或卡斯汀教授的《生物活性肽手册》[137,138,331]中。